Peptide Therapeutics intermediate
Tirzepatide - First-in-Human (NCT03142936)
First-in-human trial of tirzepatide for type 2 diabetes. This peptide or oligopeptide is studied for its biological activity, structure-activity relationship...
By Encyclopeptide Editorial | 1 min read
tirzepatide-first-in-human-nct03142936 peptide research
Overview
First-in-human trial of tirzepatide for type 2 diabetes.
Clinical Significance
This topic has important implications for peptide research and clinical applications.
References
- Encyclopeptide Database. “Tirzepatide - First-in-Human (NCT03142936)” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Tirzepatide - First-in-Human (NCT03142936) with interactive quizzes on Wikipept.
Take a Quiz on Wikipept